Physician
Marco Gutierrez MD and Associates
Marco Gutierrez MD and Associates was paid $556K by Medicaid between Jan 2018 and Dec 2024, across 74 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 59% of everything it billed.
33Billing provider infoMARCO GUTIERREZ MD AND ASSOCIATES
ALAMO, TX 78516
ALAMO, TX 78516
33aNPI1558306563assigned 06/17/2006
33bProvider typeFamily Medicine Physician
28Total paid$556K
24GClaims54,861
24DCodes billed74
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Family Medicine Physician providers in Texas
Rank by total paid#168 of 1,204
Median peer was paid$31K
This provider vs. median18×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 7,385 | $19K | |
| 2019 | 7,546 | $15K | |
| 2020 | 7,081 | $33K | |
| 2021 | 7,702 | $101K | |
| 2022 | 9,123 | $158K | |
| 2023 | 8,527 | $131K | |
| 2024incomplete | 7,497 | $100K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 59% | 9,789 | 8,133 | $330K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 11% | 1,363 | 1,300 | $61K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 9.3% | 742 | 713 | $52K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 4.4% | 999 | 960 | $25K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2.2% | 1,120 | 1,024 | $12K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.9% | 3,389 | 3,198 | $11K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 1.8% | 297 | 268 | $10K |
| 83036 | Hemoglobin; glycosylated (A1C) | 1.5% | 2,263 | 2,158 | $8K |
| 85027 | 1.1% | 1,388 | 1,290 | $6K | |
| 93000 | <1% | 888 | 826 | $5K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 66 | 66 | $5K |
| 90674 | <1% | 423 | 401 | $4K |
62 more codes
| 81002 | <1% | 3,059 | $4K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 338 | $4K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 82 | $3K |
| 82043 | <1% | 1,533 | $3K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 34 | $2K |
| 82570 | <1% | 1,540 | $2K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 40 | $2K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 44 | $2K |
| 90661 | <1% | 62 | $1K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 12 | $763.70 |
| 92250 | <1% | 21 | $540.10 | |
| 86769 | <1% | 15 | $501.35 | |
| 99000 | <1% | 77 | $480.00 | |
| 93922 | <1% | 44 | $467.68 | |
| 95923 | <1% | 43 | $322.77 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 533 | $300.97 |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 75 | $255.80 |
| 95921 | <1% | 45 | $251.67 | |
| 90688 | <1% | 18 | $166.10 | |
| 0013A | <1% | 26 | $160.00 | |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | <1% | 31 | $152.50 |
| 86328 | <1% | 15 | $131.17 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 13 | $20.27 |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 1,724 | $0.40 |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | <1% | 77 | $0.02 |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 3,348 | $0.00 |
| G8752 | Most recent systolic blood pressure < 140 mmhg | 0% | 1,944 | $0.00 |
| G8598 | Aspirin or another antiplatelet therapy used | 0% | 858 | $0.00 |
| 1159F | 0% | 162 | $0.00 | |
| 90756 | 0% | 14 | $0.00 | |
| G8783 | Normal blood pressure reading documented, follow-up not required | 0% | 604 | $0.00 |
| 3288F | 0% | 928 | $0.00 | |
| 1100F | 0% | 144 | $0.00 | |
| G8482 | Influenza immunization administered or previously received | 0% | 1,132 | $0.00 |
| 4040F | 0% | 602 | $0.00 | |
| 93925 | 0% | 27 | $0.00 | |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 715 | $0.00 |
| 98960 | 0% | 137 | $0.00 | |
| 99215 | Doctor's office visit, returning patient (complex) | 0% | 18 | $0.00 |
| 1158F | 0% | 48 | $0.00 | |
| 2000F | 0% | 448 | $0.00 | |
| G9664 | Patients who are currently statin therapy users or received an order (prescription) for statin therapy | 0% | 1,015 | $0.00 |
| 1036F | 0% | 1,600 | $0.00 | |
| 2001F | 0% | 367 | $0.00 | |
| 3017F | 0% | 1,021 | $0.00 | |
| G9903 | Patient screened for tobacco use and identified as a tobacco non-user | 0% | 612 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 0% | 184 | $0.00 |
| G8754 | Most recent diastolic blood pressure < 90 mmhg | 0% | 1,915 | $0.00 |
| 36415 | Collection of venous blood by venipuncture | 0% | 1,122 | $0.00 |
| 1101F | 0% | 807 | $0.00 | |
| G2197 | Patient screened for unhealthy alcohol use using a systematic screening method and not identified as an unhealthy alcohol user | 0% | 204 | $0.00 |
| 2010F | 0% | 621 | $0.00 | |
| 3008F | 0% | 333 | $0.00 | |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | 0% | 135 | $0.00 |
| 3044F | 0% | 113 | $0.00 | |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 1,224 | $0.00 |
| 95922 | 0% | 44 | $0.00 | |
| 1123F | 0% | 67 | $0.00 | |
| 1220F | 0% | 46 | $0.00 | |
| 0509F | 0% | 46 | $0.00 | |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 0% | 13 | $0.00 |
| G8418 | Bmi is documented below normal parameters and a follow-up plan is documented | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGUTIERREZ, MARCO (OWNER)